CPAC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cementos Pacasmayo (CPAC) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there is a potential catalyst in the form of Holcim's acquisition and a tender offer at $13 per share, the company's recent financial performance shows declining net income and EPS, which raises concerns about its profitability. Additionally, technical indicators are neutral to bearish, and there are no strong trading signals or recent news to suggest immediate upside. A hold position is recommended until further clarity on the tender offer or improved financial performance.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 31.779, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 9.962), with resistance at R1: 10.657.
Holcim's agreement to acquire Inversiones Aspi, which controls 50.01% of Cementos Pacasmayo, and the subsequent tender offer at $13 per share within six months.
Declining net income (-139.40% YoY) and EPS (-133.33% YoY) in the latest quarter. The MACD and technical indicators suggest bearish momentum. No recent news or significant trading trends from hedge funds or insiders.
In Q4 2025, revenue increased by 17.80% YoY to $165.37M, but net income dropped significantly to -$5.26M (-139.40% YoY), and EPS fell to -0.01 (-133.33% YoY). Gross margin improved to 39.3%, up 4.88% YoY.
JPMorgan upgraded CPAC to Neutral from Underweight, with a price target increase to $13 from $7.50, citing the Holcim acquisition agreement as a key driver.
